Fig. 1From: The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysisEffects of combined capecitabine regimens in neoadjuvant and adjuvant chemotherapy on disease-free survival (DFS)Back to article page